Mergers and Acquisitions

The company said it expects to transaction to close on June 16, 2017.

Thermo Fisher will acquire Patheon for approximately $7.2 billion, including the assumption of approximately $2 billion of net debt.

Fresenius Kabi enters biosimilars market with acquisition of Merck KGaA’s Biosimilars Business

Sartorius acquired the Swedish company that specializes in data analytics software for biopharmaceutical development and manufacturing.

Permira will acquire LSNE, a CDMO for the pharmaceutical and medical device markets.

The companies will split Actellion’s drug discovery and early-stage clinical development assets into a new Swiss biopharmaceutical company.

WuXi AppTech acquired HD Biosciences, a preclinical drug-discovery-focused CRO.

The combined company’s turnover is estimated to reach €8 million ($8.35M) in 2017.

AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.

Baxter will acquire Claris Injectables Limited, adding additional generic injectable capabilities to the company’s porfolio.

Lonza adds CDMO, capsule, and consumer healthcare and nutrition capabilities with $5.5-billion acquisition of Capsugel.

Neovacs acquired Amegabiotech’s Interferon Alpha manufacturing license for the manufacture of its lead therapeutic candidate.

UPS entered into a definitive purchase agreement to acquire Marken, a provider of supply-chain solutions for the life-science industry.

Astellas will acquire Ganymed and its portfolio of ideal monoclonal antibody candidates.

Constantia Flexibles acquired a flexible packaging business from Lamp San Prospero SPA.

Pfizer announced its decision to remain one company after debating the possibility of splitting Pfizer Innovative Health and Pfizer Essential Health into two, separate publicly traded companies.

Bayer will acquire the agricultural company for $66 billion in an all cash transaction.

Allergan acquired clinical-stage gene-therapy company, RetroSense Therapeutics, for $60 million.

CSafe completed the acquisition of Kallibox, a manufacturer of cold-chain packaging solutions.

The company acquired kSep Holdings, a single-use bioprocessing solutions company.

The acquisition will give Bristol-Myers Squibb full rights to Cormorant’s HuMax-IL8 antibody program.

Evonik will acquire Transferra for an undisclosed amount, and the transaction is scheduled to close at the end of July 2016

Charles River acquired Blue Stream Laboratories, an analytical contract research organization.

Merck will acquire Afferent Pharmaceuticals for $500 million in cash with the potential for additional payments.

Jazz will acquire Celator for approximately $1.5 billion.